Pay in 4 interest-free payments of $5.74 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
You do better on methylphenidate than amphetamine
While most heart palpitations are not dangerous, there are times when they could be a sign of a more serious health problem
What was studied Across 37 studies (63 treatment arms, 9,341 adults) with overweight or obesity, the authors quantified how fast #weight returns after #discontinuing #medication, and compared this with regain after behavioural weight-management programmes (#BWMPs)
Scientists identified two main hormones responsible: Glucose-dependent Insulinotropic Polypeptide (GIP) and Glucagon-like Peptide (GLP-1)
Again though, the effects in this regard are likely to be moderate or even clinically insignificant
About ATTAIN-1 and ATTAIN-2 clinical trial program The ATTAIN Phase III global clinical development program for orforglipron has enrolled more than 4,500 people with obesity or overweight across two global registration trials
US$ 29.88
US$ 24.56
US$ 22.03
US$ 29.28
US$ 25.45
US$ 20.19
